REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanofi Saglik Urunleri Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanofi Saglik Urunleri Limited Sirketi Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Sanofi Saglik Urunleri Ltd. Sti. is an enterprise in Turkiye, with the main office in Istanbul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on January 23, 2001. 800 (2024) employees currently work for Sanofi Saglik Urunleri Ltd. Sti.. In its most recent financial highlights, the company reported a net sales revenue increase of 38.43% in 2022. During that time, Sanofi Saglik Urunleri Ltd. Sti.’s total assets grew by 9.15%. The net profit margin of Sanofi Saglik Urunleri Ltd. Sti. increased by 3.64% in 2022.

Headquarters
193 Apartmani D:15 No:193 Esentepe Mahallesi Buyukdere Caddesi Sisli
Istanbul; Marmara; Postal Code: 34394

Contact Details: Purchase the Sanofi Saglik Urunleri Ltd. Sti. report to view the information.

Website: http://www.sanofi.com.tr

Basic Information
Total Employees:
Purchase the Sanofi Saglik Urunleri Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Sanofi Saglik Urunleri Ltd. Sti. report to view the information.
Incorporation Date:
January 23, 2001
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Sanofi Saglik Urunleri Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
38.43%
Total operating revenue
38.43%
Operating profit (EBIT)
73.49%
Net Profit (Loss) for the Period
73.49%
Total assets
9.15%
Total equity
-18.71%
Operating Profit Margin (ROS)
3.64%
Net Profit Margin
3.64%
Return on Equity (ROE)
33.86%
Quick Ratio
-0.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?